Search Reports:

Enter company name or symbol or keyword from report title or report description. You can also use our advanced search option to further filter your results.

Accuracy of Opinions

984 (79%) - Correct
255 (21%) - Incorrect

Explanation

Recent News on Covered Stocks

Historical Report Search

Reports on important events of publicly traded biotechnology companies that have acted as drivers for the stock. Each report provides a comprehensive insight into the event, the drug, the disease, market potential, competitive analysis and financial highlights of the company. It also discusses what our Expectations (Positive or Negative) were for the event prior to the event taking place and the rationale driving those expectations.
 
Title/Description/Keyword
Company  
Market Cap Type  
Event Type  
Disease  
Sub-disease

 
Indication

 
Product Type  
Mechanism Of Action  
 

Sample Report:

VRTX's HCV drug Telaprevir received FDA approval on May 23, 2011. New BioMedicine had issued a report on this event on May 3, 2011. To read more about the drug, the disease, the market, the competition, etc. access it at the link below.
 

Basket Reports:

Free Basket Reports

Specific theme-based reports at a value price
View Package

©Copyright 2012 New Bio Medicine, LLC. All Right Reserved.